These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8914009)

  • 1. Evaluation of efficacy of antiviral therapy for chronic hepatitis C: a EUROHEP Consensus Report on response criteria.
    Craxì A; Almasio P; Schalm S
    J Viral Hepat; 1996 Sep; 3(5):273-6. PubMed ID: 8914009
    [No Abstract]   [Full Text] [Related]  

  • 2. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
    Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
    Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in hepatitis C virus antigen in liver with antiviral therapy.
    Di Bisceglie AM; Hoofnagle JH; Krawczynski K
    Gastroenterology; 1993 Sep; 105(3):858-62. PubMed ID: 7689520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chronic hepatitis C: a consensus.
    Dienstag JL
    Gastroenterology; 1997 Aug; 113(2):375. PubMed ID: 9247451
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of histological features and outcome of interferon therapy in chronic hepatitis C.
    Kumagai N; Kuramochi S; Toda K; Iwabuchi N; Tsuchimoto K; Tsunematsu S; Saito H; Morizane T; Tsuchiya M; Ishii H
    J Gastroenterol; 1996 Feb; 31(1):69-74. PubMed ID: 8808431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged therapy of chronic hepatitis C with ribavirin.
    Hoofnagle JH; Lau D; Conjeevaram H; Kleiner D; Di Bisceglie AM
    J Viral Hepat; 1996 Sep; 3(5):247-52. PubMed ID: 8914004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of anti-viral therapy for occult hepatitis C virus infection.
    Pardo M; López-Alcorocho JM; Castillo I; Rodríguez-Iñigo E; Perez-Mota A; Carreño V
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1153-9. PubMed ID: 16611276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4.
    el-Zayadi A; Simmonds P; Dabbous H; Prescott L; Selim O; Ahdy A
    J Viral Hepat; 1996 Sep; 3(5):261-4. PubMed ID: 8914006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of liver biopsy in hepatitis C.
    Perrillo RP
    Hepatology; 1997 Sep; 26(3 Suppl 1):57S-61S. PubMed ID: 9305665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnosis of hepatitis C virus infection].
    Gervain J
    Orv Hetil; 2014 Jun; 155(26):1019-23. PubMed ID: 24954143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C.
    Colletta C; Smirne C; Marini C; Pirisi M
    J Clin Gastroenterol; 2008 Feb; 42(2):219-20. PubMed ID: 18209600
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
    Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
    Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of lack of response to antiviral therapy among in patients with recurrent hepatitis C after liver transplantation.
    Marino M; Iemmolo RM; Montalti R; Bertolotti M; Di Benedetto F; De Ruvo N; Cautero N; Guerrini G; De Blasiis MG; Gerunda GE
    Transplant Proc; 2010 May; 42(4):1223-5. PubMed ID: 20534266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological assessment of hepatitis C virus infection in parenteral drug abusers.
    Papatheodoridis GV; Delladetsima J; Verghisi-Nikolakaki S; Malliori M; Krystallis A; Hatzakis A; Tassopoulos NC
    Am J Gastroenterol; 1995 Oct; 90(10):1843-6. PubMed ID: 7572906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepatitis C virus (HCV) RNA: a reliable tool for evaluating HCV-related liver disease in anti-HCV-positive blood donors with persistently normal alanine aminotransferase values.
    Nalpas B; Romeo R; Pol S; Thiers V; Carnot F; Berthelot P; Brechot C
    Transfusion; 1995 Sep; 35(9):750-3. PubMed ID: 7570935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group.
    Shiratori Y; Kato N; Yokosuka O; Imazeki F; Hashimoto E; Hayashi N; Nakamura A; Asada M; Kuroda H; Tanaka N; Arakawa Y; Omata M
    Gastroenterology; 1997 Aug; 113(2):558-66. PubMed ID: 9247476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.